Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**TBC1 domain family member 30 (TBC1D30)** is a protein encoded by the TBC1D30 gene on human chromosome 12 (12q14.3)[1]. The protein contains a RabGAP-TBC domain and a DUF4682 domain, suggesting a putative function as a GTPase-activating protein for Rab family proteins, which are involved in vesicular trafficking[2][5]. TBC1D30 is predominantly expressed in the brain and adrenal cortex[1][3]. Experimental studies indicate roles in the regulation of cilium assembly/disassembly and possible involvement in insulin processing[1][4]. There are no approved drugs or direct therapeutics targeting this molecule, and its clinical significance remains largely uncharacterized. Possible protein-protein interactions include STX3, ZRANB1, and ESR1[1]. A single nucleotide polymorphism (rs11615287) in the RabGAP domain may be damaging, but current evidence does not specifically link TBC1D30 to major human diseases or therapeutic interventions[1][4][5].
Not applicable (no drugs known to interact)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBC1 domain family member 30 (TBC1D30).